State Street Corp Abb Vie Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, State Street Corp holds 77,800,250 shares of ABBV stock, worth $15.2 Billion. This represents 0.59% of its overall portfolio holdings.

Number of Shares

77,800,250

Previous 77,970,658 0.22%

Holding current value

$15.2 Billion

Previous $14.2 Billion 6.02%

% of portfolio

0.59%

Previous 0.64%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $26.4 Million - $30.8 Million	-170,408 Reduced 0.22%	77,800,250 $13.3 Billion
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $36.8 Million - $41.9 Million	-230,208 Reduced 0.29%	77,970,658 $14.2 Billion
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $32.7 Million - $36.9 Million	237,936 Added 0.31%	78,200,866 $12.1 Billion
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $29.3 Million - $34 Million	-219,637 Reduced 0.28%	77,962,930 $11.6 Billion
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $153 Million - $191 Million	1,156,130 Added 1.5%	78,182,567 $10.5 Billion
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $151 Million - $174 Million	-1,042,817 Reduced 1.34%	77,026,437 $12.3 Billion
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $80.6 Million - $96.7 Million	582,937 Added 0.75%	78,069,254 $12.6 Billion
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $49.2 Million - $56.4 Million	366,695 Added 0.48%	77,486,317 $10.4 Billion
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $126 Million - $161 Million	-918,574 Reduced 1.18%	77,119,622 $11.8 Billion
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $174 Million - $216 Million	-1,319,509 Reduced 1.66%	78,038,196 $12.7 Billion
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $279 Million - $353 Million	2,597,076 Added 3.38%	79,357,705 $10.7 Billion
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $84.8 Million - $96.3 Million	797,325 Added 1.05%	76,760,629 $8.28 Billion
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $49.2 Million - $54.8 Million	467,356 Added 0.62%	75,963,304 $8.56 Billion
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $273 Million - $300 Million	-2,666,116 Reduced 3.41%	75,495,948 $8.17 Billion
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $3.73 Million - $5.04 Million	-46,397 Reduced 0.06%	78,162,064 $8.38 Billion
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $130 Million - $153 Million	-1,516,594 Reduced 1.9%	78,208,461 $6.85 Billion
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $843 Million - $1.13 Billion	11,496,437 Added 16.85%	79,725,055 $7.83 Billion
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $4.4 Billion - $6.67 Billion	68,228,618 New	68,228,618 $5.2 Billion

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Abb Vie Inc. Transaction History